» Articles » PMID: 22701738

FGFR1-induced Epithelial to Mesenchymal Transition Through MAPK/PLCγ/COX-2-mediated Mechanisms

Overview
Journal PLoS One
Date 2012 Jun 16
PMID 22701738
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Tumour invasion and metastasis is the most common cause of death from cancer. For epithelial cells to invade surrounding tissues and metastasise, an epithelial-mesenchymal transition (EMT) is required. We have demonstrated that FGFR1 expression is increased in bladder cancer and that activation of FGFR1 induces an EMT in urothelial carcinoma (UC) cell lines. Here, we created an in vitro FGFR1-inducible model of EMT, and used this model to identify regulators of urothelial EMT. FGFR1 activation promoted EMT over a period of 72 hours. Initially a rapid increase in actin stress fibres occurred, followed by an increase in cell size, altered morphology and increased migration and invasion. By using site-directed mutagenesis and small molecule inhibitors we demonstrated that combined activation of the mitogen activated protein kinase (MAPK) and phospholipase C gamma (PLCγ) pathways regulated this EMT. Actin stress fibre formation was regulated by PLCγ activation, and was also important for the increase in cell size, migration and altered morphology. MAPK activation regulated migration and E-cadherin expression, indicating that combined activation of PLCγ and MAPK is required for a full EMT. We used expression microarrays to assess changes in gene expression downstream of these signalling cascades. COX-2 was transcriptionally upregulated by FGFR1 and caused increased intracellular prostaglandin E(2) levels, which promoted migration. In conclusion, we have demonstrated that FGFR1 activation in UC cells lines promotes EMT via coordinated activation of multiple signalling pathways and by promoting activation of prostaglandin synthesis.

Citing Articles

Intercellular signaling stabilizes single-cell level phenotypic transitions and accelerates the reestablishment of equilibrium of heterogeneous cancer cell populations.

Lopez D, Tyson D, Hong T bioRxiv. 2025; .

PMID: 39803530 PMC: 11722408. DOI: 10.1101/2025.01.03.631250.


Landscape of targeted therapies for advanced urothelial carcinoma.

Shang S, Zhang L, Liu K, Lv M, Zhang J, Ju D Explor Target Antitumor Ther. 2024; 5(3):641-677.

PMID: 38966172 PMC: 11220318. DOI: 10.37349/etat.2024.00240.


Shake It Up Baby Now: The Changing Focus on TWIST1 and Epithelial to Mesenchymal Transition in Cancer and Other Diseases.

Mirjat D, Kashif M, Roberts C Int J Mol Sci. 2023; 24(24).

PMID: 38139368 PMC: 10743446. DOI: 10.3390/ijms242417539.


Bladder cancer.

Dyrskjot L, Hansel D, Efstathiou J, Knowles M, Galsky M, Teoh J Nat Rev Dis Primers. 2023; 9(1):58.

PMID: 37884563 PMC: 11218610. DOI: 10.1038/s41572-023-00468-9.


Spatial distribution and functional relevance of FGFR1 and FGFR2 expression for glioblastoma tumor invasion.

Alshahrany N, Begum A, Siebzehnrubl D, Jimenez-Pascual A, Siebzehnrubl F Cancer Lett. 2023; 571:216349.

PMID: 37579831 PMC: 10840508. DOI: 10.1016/j.canlet.2023.216349.


References
1.
Inoue H, Tanabe T, Umesono K . Feedback control of cyclooxygenase-2 expression through PPARgamma. J Biol Chem. 2000; 275(36):28028-32. DOI: 10.1074/jbc.M001387200. View

2.
Yang Y, Pan X, Lei W, Wang J, Shi J, Li F . Regulation of transforming growth factor-beta 1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3. Cancer Res. 2006; 66(17):8617-24. DOI: 10.1158/0008-5472.CAN-06-1308. View

3.
Yang W, FRUCHT H . Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis. 2001; 22(9):1379-83. DOI: 10.1093/carcin/22.9.1379. View

4.
Shirahama T, ARIMA J, Akiba S, Sakakura C . Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. Cancer. 2001; 92(1):188-93. DOI: 10.1002/1097-0142(20010701)92:1<188::aid-cncr1308>3.0.co;2-w. View

5.
Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E . TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 1996; 10(19):2462-77. DOI: 10.1101/gad.10.19.2462. View